Rule 170 of the Drugs and Cosmetics Rules
On 27th August, 2024, the Supreme Court of India, while hearing the case against Patanjali Ayurved, pulled up the AYUSH Ministry for its July 1, 2024, notification asking state licensing authorities “not to initiate/take any action under” Rule 170 of the Drugs and Cosmetics Act, 1940.
What is Rule 170?
- Introduction Date: It was introduced in 2018 to govern the manufacture, storage, and sale of medicines in the country, “specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines”.
- Rationale: The rule was introduced after a parliamentary standing committee highlighted the problem of misleading claims, and the need for the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 SC Seeks Centre’s Report on SC/ST Sub-Classification Verdict
- 2 SC Lays Down 4-Factor Test to Avoid Undue Sympathy in Sentencing
- 3 MoSPI Releases New CPI Series with 2024 Base Year
- 4 Supreme Court Slams State Governments Over Freebies
- 5 Bharat Taxi: India’s First Cooperative-based Taxi Service
- 6 Centre Launches AI Health Initiatives: SAHI and BODH
- 7 Political Leaders Must Foster Fraternity: SC
- 8 Private Member's Bill
- 9 Government Revises Startup Recognition Framework
- 10 AI-Driven Reforms in India’s Public Distribution System
